Robert Weisman

Weisman covers the healthcare and life sciences industries for the Business section. He was a business reporter and editor for the Hartford Courant and the Seattle Times before joining the Globe in 2000.

Latest stories

Burlington biotech Flexion could be sold to Sanofi

By , Globe Staff

Company’s stock price skyrockets on a report that it’s negotiating with the French drug maker.

Biogen wins patent ruling for its $4 billion MS treatment

By , Globe Staff

Shares of Biogen were trading up 1.5 percent after the Cambridge biotech’s patent was upheld in court.

Biopharma facing stiffer opposition

By , Globe Staff

The backlash against steep drug prices has become a rare subject of bipartisan agreement in Washington, D.C.

Seres to launch new drug trial to treat hospital infections

By , Globe Staff

Disappointing results from earlier testing caused stock to plunge.